BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
BIOHARVEST SCIENCES INC.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.80−0.05 (-2.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Bioharvest Sciences has not reported a dividend
No dividend per share appears in Bioharvest Sciences's annual filings since fiscal 2022.